The prevalence of epilepsy is highest in the Central Africa subregion most especially in rural settlements. This is further compounded by a high prevalence of treatment gap, from poor drug adherence, and poor road network. One approach to overcoming this burden is to leverage Video-based Directly Observed Therapy (ViDOT) use for stable patients living with epilepsy, harnessing the advancement in mHealth technologies, and widespread adoption of smartphones. ViDOT is a form of telemedicine that is a smartphone-based, treatment approach for monitoring and evaluating remote patients.
Objective
We performed a narrative review of the existing literature using electronic databases from PubMed and Google Scholar to identify relevant publications related to ViDOT and chronic diseases, in particular epilepsy.
Methods
The selected articles were assessed for relevance, and key findings were synthesized to provide an overview of the role of ViDOT in addressing the challenges of drug adherence in epilepsy.
Results
The review shows that poor drug adherence is a major risk for poor outcomes in patients living with epilepsy. ViDOT has the potential to significantly contribute to improved drug adherence in patients living with epilepsy. Other benefits of ViDOT include the elimination of prolonged waiting times, improvement in access to specialized care, eradication of self-induced stigma and discrimination, diminishing neurologists’ workload, and cost-effectiveness. Challenges include poor network coverage and unstable internet service.
Conclusion
Giving a brief psychoeducation about epilepsy, anti-epileptic drug (AED) side effects, and the importance of sticking with the recommended drug use can improve AED adherence and epilepsy outcomes. Information dissemination through ViDOT to people with epilepsy and their caregivers at large is important to promote a healthy life.
AhmedS. N.MannC.SinclairD. B.HeinoA.IskiwB.QuigleyD.OhinmaaA. (2008). Feasibility of epilepsy follow-up care through telemedicine: a pilot study on the patient’s perspective. Epilepsia, 49(4), 573–585. https://doi.org/10.1111/j.1528-1167.2007.01464.x.
5.
Al-AqeelS.Al-SabhanJ. (2011). Strategies for improving adherence to antiepileptic drug treatment in patients with epilepsy. Cochrane Database Syst Rev, (1), Cd008312. https://doi.org/10.1002/14651858.CD008312.pub2.
6.
Al-AqeelS.GershuniO.Al-SabhanJ.HiligsmannM. (2017). Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy. Cochrane Database Syst Rev, 2(2), Cd008312. https://doi.org/10.1002/14651858.CD008312.pub3.
7.
BabuY.ShelemeT.SeferaB.BekeleF.OlikaW. (2023). Magnitude of uncontrolled seizures and associated factors among people with epilepsy. Data from a major teaching hospital in Southwest Ethiopia. Epilepsy Behav, 140, 109089. https://doi.org/10.1016/j.yebeh.2023.109089.
8.
BahraniK.SinghM. B.BhatiaR.PrasadK.VibhaD.ShuklaG.VishnubhatlaS.PattersonV. (2017). Telephonic review for outpatients with epilepsy-A prospective randomized, parallel group study. Seizure, 53, 55–61. https://doi.org/10.1016/j.seizure.2017.11.003.
9.
BahraniK.SinghM. B.BhatiaR.PrasadK.VibhaD.ShuklaG.VishnubhatlaS.PattersonV. (2017). Telephonic review for outpatients with epilepsy— A prospective randomized, parallel-group study. Seizure, 53, 55–61.
10.
BenbadisS. R. (2023). The Best Seizure Diagnostic Tool Is Not a Medical Device: Why Stand-Alone Video Review Needs a Current Procedural Terminology Code. Neurol Clin Pract, 13(1), e200117. https://doi.org/10.1212/cpj.0000000000200117.
11.
CarterJ. A.MolyneuxC. S.MbubaC. K.JenkinsJ.NewtonC. R.HartleyS. D. (2012). The reasons for the epilepsy treatment gap in Kilifi, Kenya: using formative research to identify interventions to improve adherence to antiepileptic drugs. Epilepsy Behav, 25(4), 614–621. https://doi.org/10.1016/j.yebeh.2012.07.009.
12.
FadareJ. O.SunmonuT. A.BankoleI. A.AdekeyeK. A.AbubakarS. A. (2018). Medication adherence and adverse effect profile of antiepileptic drugs in Nigerian patients with epilepsy. Neurodegener Dis Manag, 8(1), 25–36. https://doi.org/10.2217/nmt-2017-0044.
13.
FanK.ZhaoY. (2022). Mobile health technology: a novel tool in chronic disease management. Intelligent Medicine, 2(1), 41–47.
14.
FarghalyW. M.El-TallawyH. N.RagehT. A.MohamedE. M.MetwallyN. A.ShehataG. A.BadryR.Abd-ElhamedM. A. (2013). Epidemiology of uncontrolled epilepsy in the Al-Kharga District, New Valley, Egypt. Seizure, 22(8), 611–616. https://doi.org/10.1016/j.seizure.2013.04.010.
15.
FeldmeierG.LöfflerC.AltinerA.WollnyA.von PodewilsF.RitzkeM. (2022). Audiovisual teleconsultation for patients with epilepsy in primary care in rural Germany: a pilot study on feasibility and acceptance. Pilot and Feasibility Studies, 8(1), 213.
JangY.MoonJ.LeeS. T.LeeS. K.ChuK. (2022). Telemedicine in epilepsy and encephalitis: previous research and indication guidelines in Korea. Encephalitis, 2(3), 65–72. https://doi.org/10.47936/encephalitis.2022.00024.
18.
JothiA.RamamoorthyL.NairP. P. (2020). The Effect of Comprehensive Video-Assisted Epilepsy Education on Drug Adherence and Self-Care in People with Epilepsy. J Neurosci Rural Pract, 11(4), 538–544. https://doi.org/10.1055/s-0040-1713841.
19.
KaraG. C.YalcinB. M. (2022). Comparison of In-Person vs. Video Directly Observed Therapy (VDOT) on Stigma Levels in Tuberculosis Patients. J Am Board Fam Med. https://doi.org/10.3122/jabfm.2022.AP.210514.
20.
KassieA. M.AbateB. B.KassawM. W.GetieA.WondmienehA.TegegneK. M.AhmedM. (2021). Quality of life and its associated factors among epileptic patients attending public hospitals in North Wollo Zone, Northeast Ethiopia: A cross-sectional study. PloS One, 16(2), e0247336. https://doi.org/10.1371/journal.pone.0247336.
21.
KonstantinouP.KassianosA. P.GeorgiouG.PanayidesA.PapageorgiouA.AlmasI.WozniakG.KareklaM. (2020). Barriers, facilitators, and interventions for medication adherence across chronic conditions with the highest non-adherence rates: a scoping review with recommendations for intervention development. Transl Behav Med, 10(6), 1390–1398. https://doi.org/10.1093/tbm/ibaa118.
22.
LaFranceW. C.JrHoW. L. N.BhatlaA.BairdG. L.AltalibH. H.GodleskiL. (2020). Treatment of psychogenic nonepileptic seizures (PNES) using video telehealth. Epilepsia, 61(11), 2572–2582.
23.
LiT.ChenJ.HuC.MaY.WuZ.WanW.HuangY.JiaF.GongC.WanS.LiL. (2018). Automatic Timed Up-and-Go Sub-Task Segmentation for Parkinson’s Disease Patients Using Video-Based Activity Classification. IEEE Trans Neural Syst Rehabil Eng, 26(11), 2189–2199. https://doi.org/10.1109/tnsre.2018.2875738.
24.
Llorens-VernetP.MiróJ. (2020). Standards for Mobile Health-Related Apps: Systematic Review and Development of a Guide. JMIR Mhealth Uhealth, 8(3), e13057. https://doi.org/10.2196/13057.
25.
ManganJ. M.WoodruffR. S.WinstonC. A.NabityS. A.HaddadM. B.DixonM. G.ParvezF. M.Sera-JosefC.Salmon-TrejoL. A. T.LamC. K. (2023). Recommendations for Use of Video Directly Observed Therapy During Tuberculosis Treatment - United States, 2023. MMWR Morb Mortal Wkly Rep, 72(12), 313–316. https://doi.org/10.15585/mmwr.mm7212a4.
26.
MirpuriP.ChandraP. P.SamalaR.AgarwalM.DoddamaniR.KaurK.RamanujanB.ChandraP. S.TripathiM. (2021). The development and efficacy of a mobile phone application to improve medication adherence for persons with epilepsy in limited resource settings: A preliminary study. Epilepsy & Behavior, 116, 107794.
27.
NairP. P.AghoramR.ThomasB.BharadwajB.ChinnakaliP. (2021). Video teleconsultation services for persons with epilepsy during COVID- pandemic: An exploratory study from public tertiary care hospital in Southern India on feasibility, satisfaction, and effectiveness. Epilepsy Behav, 117, 107863. https://doi.org/10.1016/j.yebeh.2021.107863.
28.
NavarroO.EscriváM.FaubelR.TraverV. (2021). Empowering Patients Living With Chronic Conditions Using Video as an Educational Tool: Scoping Review. J Med Internet Res, 23(7), e26427. https://doi.org/10.2196/26427.
29.
OdetundeM. O.BinuyoO. T.MarufF. A.AyenowowonS. O.OkonjiA. M.OdetundeN. A.MbadaC. E. (2020). Development and Feasibility Testing of Video Home Based Telerehabilitation for Stroke Survivors in Resource Limited Settings. Int J Telerehabil, 12(2), 125–136. https://doi.org/10.5195/ijt.2020.6321.
30.
OwolabiL. F.AdamuB.JiboA. M.OwolabiS. D.IsaA. I.AlhajiI. D.EnwereO. O. (2020). Prevalence of active epilepsy, lifetime epilepsy prevalence, and burden of epilepsy in Sub-Saharan Africa from meta-analysis of door-to-door population-based surveys. Epilepsy Behav, 103(Pt A), 106846. https://doi.org/10.1016/j.yebeh.2019.106846.
31.
OwolabiL. F.OwolabiS. D.AdamuB.JiboA. M.AlhajiI. D. (2020). Epilepsy treatment gap in Sub-Saharan Africa: Meta-analysis of community-based studies. Acta Neurol Scand, 142(1), 3–13. https://doi.org/10.1111/ane.13246.
32.
OyewunmiO. F.ObayeluO. A. (2023). Poverty status of rural households in Nigeria: a gendered perspective. International Journal of Social Economics, 50(2), 260–278.
33.
PattersonV. (2020). The development of a smartphone application to help manage epilepsy in resource-limited settings. Seizure, 79, 69–74.
34.
SarfoF. S.AdamuS.AwuahD.OvbiageleB. (2017). Tele-neurology in sub-Saharan Africa: A systematic review of the literature. J Neurol Sci, 380, 196–199. https://doi.org/10.1016/j.jns.2017.07.037.
35.
StonerM. C. D.Maragh-BassA. C.Sukhija-CohenA. C.SaberiP. (2022). Digital directly observed therapy to monitor adherence to medications: a scoping review. HIV Res Clin Pract, 23(1), 47–60.
36.
TatumW. O.HirschL. J.GelfandM. A.ActonE. K.LaFranceW. C.JrDuckrowR. B.ChenD. K.BlumA. S.HixsonJ. D.DrazkowskiJ. F.BenbadisS. R.CascinoG. D. (2020). Assessment of the Predictive Value of Outpatient Smartphone Videos for Diagnosis of Epileptic Seizures. JAMA Neurol, 77(5), 593–600. https://doi.org/10.1001/jamaneurol.2019.4785.
37.
XuK.LiuL. M.FaraziP. A.WangH.RochlingF. A.Watanabe-GallowayS.ZhangJ. J. (2018). Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B. Glob Health Action, 11(1), 1433987. https://doi.org/10.1080/16549716.2018.1433987.
